COVID‐19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience

Substantial changes in the management of cancer patients have been required worldwide in response to the COVID‐19 pandemic. Beyond the due details on the primitive cancer site and setting at diagnosis, these latter adaptions are most commonly exemplified by a significant reduction in the screening o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast J
Main Authors: Barba, Maddalena, Krasniqi, Eriseld, Pizzuti, Laura, Mazzotta, Marco, Marinelli, Daniele, Giuliano, Greta, Di Liso, Francesca Sofia, Cappuzzo, Federico, Landi, Lorenza, Tomao, Silverio, Ciliberto, Gennaro, Vici, Patrizia
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Short Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8251317/
https://ncbi.nlm.nih.gov/pubmed/33677841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tbj.14204
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados